8-KOther Events

QUEST DIAGNOSTICS INC 8-K Report (Jul 3, 2001)

Filed July 3, 2001For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) has filed an 8-K report detailing a significant refinancing of its long-term debt, completed on June 27, 2001. The company successfully issued $550 million in senior notes and secured a new $500 million senior unsecured credit facility, which includes a $175 million term loan. The proceeds were primarily used to retire its existing $584 million senior secured facility and to complete a tender offer for its 10 3/4% senior subordinated notes due 2006. This strategic move is projected to reduce the company's annual interest expense by approximately $23 million, indicating a positive impact on profitability and financial flexibility. The new debt structure includes a mix of maturities, with $275 million in 6.75% senior notes due 2006 and $275 million in 7.50% senior notes due 2011. Investors should note the improved debt profile and expected cost savings.

Key Highlights

  • 1Completed a major debt refinancing on June 27, 2001.
  • 2Issued $550 million in senior notes (two tranches: 6.75% due 2006, 7.50% due 2011).
  • 3Entered into a new $500 million senior unsecured credit facility, including a $175 million term loan and a $325 million revolving credit facility.
  • 4Used proceeds to repay $584 million of existing senior secured debt and costs associated with interest rate swaps.
  • 5Successfully completed a cash tender offer for nearly all ($147 million out of $150 million) of its 10 3/4% senior subordinated notes due 2006.
  • 6Expects annual interest expense savings of approximately $23 million due to the refinancing.
  • 7New credit facility includes covenants on financial ratios, additional indebtedness, share repurchases, investments, and acquisitions.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report on the completion of Quest Diagnostics' significant refinancing of its long-term debt, which took place on June 27, 2001. This included issuing new debt and entering into a new credit facility.

The refinancing is expected to significantly benefit Quest Diagnostics by reducing its annual interest expense by approximately $23 million. This is achieved through a combination of new, potentially lower-interest debt and the retirement of older, higher-cost debt.

The new debt structure consists of $550 million in senior notes, split into two tranches: $275 million of 6.75% senior notes due 2006 and $275 million of 7.50% senior notes due 2011. Additionally, the company entered into a $500 million senior unsecured credit facility, which includes a $175 million term loan and a $325 million revolving credit facility.

The proceeds from the new senior notes and term loan were used to repay all $584 million outstanding under the company's previous senior secured facility. Furthermore, the company completed a cash tender offer, successfully repurchasing nearly all of its outstanding 10 3/4% senior subordinated notes due 2006.